SAN DIEGO, Oct. 27, 2025 (GLOBE NEWSWIRE) -- DiCello Levitt LLP announces that a class action lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ: MLTX), along with certain individuals, alleging that they violated federal securities laws by issuing false and/or misleading statements concerning the Company’s business, operations, and prospects. The suit is brought on behalf of all those who purchased or otherwise acquired MoonLake common stock between March 10, 2024 through September 29, 2025, ...